Salivary Gland Cancer

Our head and neck specialists are experienced in using highly technical procedures to remove salivary gland cancer while preserving or reconstructing important nerves. A team of experts, including ear, nose, and throat specialists called otolaryngologists, surgeons, radiation oncologists, and medical oncologists, works together to provide evidence-based, compassionate care. Rehabilitation experts manage any treatment-related side effects, and integrative medicine specialists offer services to support your overall wellbeing.

Clinical Trials and Research Studies

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 2

A PHASE 2 STUDY OF ALKS 4230 IN COMBINATION WITH ANTI-PD-1 (PEMBROLIZUMAB) IN PATIENTS WITH ADVANCED OR RECURRENT HEAD AND NECK SQUAMOUS CELL CANCER CURRENTLY ON TREATENT WITH ANTI-PD-(L)1 WITHOUT HAVING ACHIEVED A COMPLETE REMISSION

Learn More

Phase 1

A Phase 1 Open Label Multi-Arm Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors

Learn More

Phase 6

Site for Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

Learn More